Clinical Research Directory
Browse clinical research sites, groups, and studies.
COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction
Sponsor: University Hospital, Montpellier
Summary
This study evaluates the benefit of colchicine on induced denervation after myocardial infarction. Patients who have suffered a documented De Novo myocardial infarction and completed a revascularization procedure will receive either colchicine on top of standard therapy, compared to standard therapy alone (1:1 allocation ratio). Colchicine 1mg (or 0.5mg) will be initiated within 48h after percutaneous revascularization and prescribed for one month.
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
54
Start Date
2020-12-04
Completion Date
2022-05-24
Last Updated
2026-06-12
Healthy Volunteers
No
Conditions
Interventions
Colchicine
1 mg (or 0.5mg) tablet of colchicine taken once a day for 1 month
Locations (1)
UH Montpellier
Montpellier, France